NEOPLASMS BY SITE
Clinical trials for NEOPLASMS BY SITE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY SITE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted pill trial for Tough-to-Treat lung cancer halted
Disease control TerminatedThis study aimed to see if a daily pill called pralsetinib works better than standard chemotherapy as the first treatment for people with advanced lung cancer that has spread and has a specific genetic change called a RET fusion. It involved 223 participants worldwide who had not…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New targeted cancer drug tested in patients who ran out of options
Disease control TerminatedThis early-stage study tested a new targeted cancer drug called EO-3021 in adults with advanced stomach and other digestive cancers that had stopped responding to standard treatments. The main goal was to find a safe dose and see if the drug caused tumors to shrink. The study was…
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE1 • Sponsor: Elevation Oncology • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Terminated trial tests Last-Chance drugs for tough kidney cancers
Disease control TerminatedThis study tested two different drug combinations for people with advanced kidney cancer that had stopped responding to standard treatments. The trial aimed to find safe doses and see if these combinations could shrink tumors or slow disease progression. The study was terminated …
Matched conditions: NEOPLASMS BY SITE
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC